Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Am Heart J. 2010 Aug;160(2):279–285. doi: 10.1016/j.ahj.2010.05.022

Table 1.

Baseline Participant Characteristics

Characteristic Overall
(N=2907)
Heart failure
(N = 342)
No heart
failure
(N = 2565)
P
Value
Age, years 73.6 (2.9) 74.2 (2.9) 73.5 (2.9) <0.001
Female, N (%) 1513 (52.0) 156 (45.6) 1357 (52.9) 0.010
Black race, N (%) 1201 (41.3) 163 (47.4) 1038 (40.5) 0.015
Smoking status, N (%)
      Current 305 (10.5) 51 (15.0) 254 (9.9) <0.001
      Past 1311 (45.2) 167 (49.0) 1144 (44.7)
Body mass index, kg/m2, N (%)
      < 25 947 (32.6) 107 (31.3) 840 (32.8) 0.001
      25–30 1222 (42.0) 121 (35.4) 1101 (42.9)
      >30 738 (25.4) 114 (33.3) 624 (24.3)
Systolic blood pressure, mm Hg 136.0 (21.0) 142.8 (23.3) 135.1 (20.5) <0.001
Diastolic blood pressure, mm Hg 71.4 (11.7) 72.9 (12.9) 71.2 (11.5) 0.061
Heart rate, beats per min 65.3 (11.0) 67.4 (12.3) 65.0 (10.8) 0.002
Hypertension, N (%) 1257 (43.5) 188 (55.1) 1069 (42.0) <0.001
Diabetes, N (%) 424 (14.7) 72 (21.1) 352 (13.8) <0.001
Depression, N (%) 60 (2.1) 7 (2.1) 53 (2.1) 0.576
Cerebrovascular disease, N (%) 197 (6.8) 33 (9.9) 164 (6.5) <0.001
Coronary heart disease, N (%) 472 (16.5) 111 (33.0) 361 (14.3) <0.001
Left ventricular hypertrophy, N (%) 346 (11.9) 56 (16.4) 290 (11.3) 0.006
Fasting glucose, mg/dL 104.0 (34.2) 112.3 (45.0) 102.9 (32.3) <0.001
Albumin, g/L 39.8 (3.1) 39.6 (3.1) 39.8 (3.1) 0.216
Creatinine, mg/dL 1.05 (0.4) 1.15 (0.5) 1.0 (0.4) <0.001
Total cholesterol, mg/dL 203.2 (38.3) 199.4 (39.3) 203.7 (38.1) 0.052
High density lipoprotein, mg/dL 54.3 (17.0) 52.0 (17.1) 54.6 (17.0) 0.001
Low density lipoprotein, mg/dL 121.9 (34.6) 120.0 (34.8) 122.2 (34.5) 0.190
Triglycerides, mg/dL 136.9 (77.0) 137.3 (71.9) 136.8 (77.7) 0.575
Interleukin-6, pg/mL 2.4 (1.9) 2.9 (2.1) 2.3 (1.8) <0.001
C-reactive protein, µg/mL 3.0 (4.7) 3.8 (6.5) 2.9 (4.7) <0.001
Tumor necrosis factor α, pg/mL 3.4 (1.7) 3.9 (1.9) 3.4 (1.7) <0.001